[시장보고서]진료 단위형 의료 서비스 시장 : 제품 유형별, 용도별, 유통 채널별, 지역별

진료 단위형 의료 서비스 시장 : 제품 유형별, 용도별, 유통 채널별, 지역별

Per-Encounter Medical Market, By Product Type, By Application, By Distribution Channel, By Geography

상품코드 : 1741511

리서치사 : Coherent Market Insights

발행일 : 2025년 03월

페이지 정보 : 영문

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,676,000

Unprintable PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 7,000

￦ 10,385,000

PDF & Excel (Multi User License - Up to 7 Users)

PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

US $ 10,000

￦ 14,837,000

PDF & Excel (Corporate User License)

PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

진료 단위형 의료 서비스 시장은 2025년에는 1,562억 5,000만 달러, 2032년에는 4,416억 달러에 이를 것으로 예측되며, 2025년부터 2032년에 걸쳐 CAGR 16%로 성장할 전망입니다.

보고 범위		보고서 세부정보
기준 연도	2024년	2025년 시장 규모	1,562억 5,000만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간 : 2025-2032년 CAGR :	16.00%	2032년 가치 예측	4,416억 달러

진료 단위형 의료 서비스는 기존의 피포 서비스 모델이 아닌 방문당 제공되는 의료 서비스입니다.

세계의 진료 단위형 의료 서비스 시장은 다양한 요인에 의해 큰 성장을 이루고 있습니다.

시장 역학 :

세계의 진료 단위형 의료 서비스 시장은 몇 가지 촉진요인에 의해 지원되고 있습니다. 의료비 상승으로 인해 환자들은 경제적으로 실행 가능한 대체 치료 옵션을 찾고 있습니다. 또한 만성 질환 증가나 고령화도, 창구 의료 서비스 수요를 높이고 있습니다. Cancer Facts &Figures' 보고서에 따르면 미국에서는 약 190만명이 새롭게 암으로 진단되었으며 60만9,360명이 사망한 것으로 보고되었습니다.

그러나 시장에 억제요인도 있습니다. 보험 상환 정책의 부족과 표준화된 규제와 정책의 부재는 진료 단위형 의료 서비스 시장의 성장을 방해할 가능성이 있습니다.

이러한 과제에도 불구하고 진료 단위형 의료 서비스 시장에는 충분한 비즈니스 기회가 있습니다. 이러한 기술을 통해 의료 제공자는 소외된 지역에 도달하여 가상으로 의료 서비스를 제공함으로써 진료 단위형 의료 서비스의 성장을 촉진할 수 있습니다.

본 조사의 주요 특징

본 보고서에서는 세계의 진료 단위형 의료 서비스 시장을 상세하게 분석했으며, 2024년을 기준연도로서, 2025년부터 2032년까지의 예측 기간에 있어서 시장 규모 및 CAGR을 제공합니다.
또, 다양한 부문에 걸친 잠재적인 수익 기회를 밝혀, 이 시장의 매력적인 투자 제안 매트릭스에 대해서 해설했습니다.
또 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 주요 고찰도 제공합니다.
본 보고서에서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터에 근거해 세계의 진료 단위형 의료 서비스장에 있어서의 주요 기업 프로파일을 제공합니다.
본 보고서로부터의 통찰에 의해 마케팅 담당자나 기업의 경영진은 장래의 제품 발매, 유형 업, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
이 조사 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 하고 있습니다.
이해관계자는 세계의 진료 단위형 의료 서비스 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

기업 프로파일
- Catalent Inc.
- Smiths Medical Inc.
- Cardinal Health
- Schott
- Nipro Corporation
- Terumo Corporation
- Gerresheimer AG
- Becton, Dickinson and Company
- Braun Melsungen AG
- AngioDynamics Inc.
- Teleflex Incorporated
- Argon Medical Devices, Inc.
- ICU Medical, Inc.
- Medical Components, Inc.
- Vygon(UK) Ltd

제10장 섹션

참고문헌
조사 방법
출판사에 대해

SHW

영문 목차

영문목차

Per-Encounter Medical Market is estimated to be valued at USD 156.25 Bn in 2025 and is expected to reach USD 441.6 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 156.25 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	16.00%	2032 Value Projection:	USD 441.6 Bn

Per-encounter medical services refer to medical treatments provided on a per-visit basis, rather than the traditional fee-for-service model. This approach is revolutionizing the healthcare landscape by offering more cost-effective and convenient care options for patients.

Global per-encounter medical market is experiencing considerable growth due to various factors. Patients are increasingly seeking more affordable healthcare options, and per-encounter medical services provide an attractive alternative. Advancements in technology have made it possible to deliver high-quality care remotely, further driving the demand for per-encounter medical services.

Market Dynamics:

Global per-encounter medical market is propelled by several drivers. Firstly, the rising healthcare costs are prompting patients to seek alternative care options that are economically viable. Per-encounter medical services offer transparent pricing and allow patients to pay only for the services they need, thus making healthcare more accessible. Moreover, the increasing prevalence of chronic diseases and the aging population further contribute to the demand for per-encounter medical services. Increasing prevalence of diseases such as cancer and end stage renal disease, which require longer duration therapies (dialysis and chemotherapy) is expected to drive the market growth. For instance, in January 2022according to data published in the Cancer Facts & Figures report by the American Cancer Society, , around 1.9 million new cancer cases was estimated to be diagnosed and 609,360 cancer deaths were reported in the U.S.

However, the market also has restraints. Lack of reimbursement policies and the absence of standardized regulations can hinder the growth of the per-encounter medical market. There may be concerns regarding the quality and continuity of care, as per-encounter medical services focus more on episodic care rather than comprehensive medical management.

Despite these challenges, the per-encounter medical market presents ample opportunities. The growing adoption of telemedicine and remote monitoring technologies provide a potential avenue for expansion. These technologies enable healthcare providers to reach underserved areas and offer healthcare services virtually, thereby fostering the growth of per-encounter medical services. Furthermore, collaborations between healthcare providers and insurance companies can help address reimbursement concerns and drive market growth.

Key features of the study:

This report provides in-depth analysis of the global per-encounter medical market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global per-encounter medical market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Catalent Inc., Smiths Medical Inc., Cardinal Health, Schott, Nipro Corporation, Terumo Corporation, Gerresheimer AG, Becton, Dickinson and Company, B. Braun Melsungen AG, AngioDynamics Inc., Teleflex Incorporated, Argon Medical Devices, Inc., ICU Medical, Inc., Medical Components, Inc., and Vygon (UK) Ltd
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global per-encounter medical market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global per-encounter medical market

Detailed Segmentation:

Global Per-Encounter Medical Market, By Product Type
- Consumables
- Devices
- Software
- Services
- Others
Global Per-Encounter Medical Market, By Application
- Cardiology
- Orthopedics
- Obstetrics/Gynecology
- Ophthalmology
- Gastroenterology
- Others
Global Per-Encounter Medical Market, By Distribution Channel
- Direct Tender
- Retail Sales
- Online Sales
Global Per-Encounter Medical Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- Catalent Inc.
- Smiths Medical Inc.
- Cardinal Health
- Schott
- Nipro Corporation
- Terumo Corporation
- Gerresheimer AG
- Becton, Dickinson and Company
- B.Braun Melsungen AG
- AngioDynamics Inc.
- Teleflex Incorporated
- Argon Medical Devices, Inc.
- ICU Medical, Inc.
- Medical Components, Inc.
- Vygon (UK) Ltd

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Rising prevalence of chronic diseases
- Stringent regulatory requirements
- Emerging markets expansion
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global Per-Encounter Medical Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Per-Encounter Medical Market, By Product Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Per-Encounter Medical Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Orthopedics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Obstetrics/Gynecology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Ophthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Gastroenterology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Per-Encounter Medical Market, By Distribution Channel, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Direct Tender
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Retail Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Online Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Per-Encounter Medical Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Argentina
  - Brazil
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - South Africa
  - Central Africa
  - North Africa

9. Competitive Landscape

Company Profile
- Catalent Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Smiths Medical Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Cardinal Health
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Schott
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Nipro Corporation
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Terumo Corporation
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Gerresheimer AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Becton, Dickinson and Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Braun Melsungen AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- AngioDynamics Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Teleflex Incorporated
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Argon Medical Devices, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- ICU Medical, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Medical Components, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Vygon (UK) Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views

10. Section

References
Research Methodology
About us

한글목차

시장 역학 :

본 조사의 주요 특징

목차

제1장 조사의 목적과 전제조건

제2장 시장 전망

제3장 시장 역학, 규제, 동향 분석

제4장 세계의 진료 단위형 의료 서비스 시장, 코로나 바이러스(COVID-19) 유행의 영향

제5장 세계의 진료 단위형 의료 서비스 시장, 제품 유형별, 2020년-2032년

제6장 세계의 진료 단위형 의료 서비스 시장, 용도별, 2020년-2032년

제7장 세계의 진료 단위형 의료 서비스 시장, 유통 채널별, 2020년-2032년

제8장 세계의 진료 단위형 의료 서비스 시장, 지역별, 2020년-2032년

제9장 경쟁 구도